Table 2 Results of metadata.

From: Hypomania and saccadic changes in Parkinson’s disease: influence of D2 and D3 dopaminergic signalling

Patients

   Number

n = 33

   Gender

m = 19; f = 14

   Age (years)

68.12 ± 8.16*

UPDRS-III

   ON

22.85 ± 1.96**

   OFF

31.21 ± 2.31**

   Hoehn and Yahr

2.29 ± 0.09**

   Disease duration (years)

6.82 ± 0.76**

   Symptom onset right (r); left (l)

r = 18, l = 15

   LEDD

506.1 ± 59.23**

PD subtype

   AR

n = 18

   TD

n = 3

   MT

n = 12

   LI (in decile)

+85.95 ± 2.56**

   MMSE

28.12 ± 0.36**

   BDI-II

10.06 ± 1.25**

   BIS-11

58.67 ± 1.35**

   HPS

8.91 ± 0.91**

   DRD3 B1+/B1−

14/19

   DRD2 A1+/A1−

12/21

Controls

   Number

n = 14

   Age

65.07 ± 6.89*

  1. *Values are given as mean ± SD
  2. **Values are given as mean ± S.E.M
  3. All relevant patient’s metadata are summarised
  4. UPDRS-III part III of the Unified Parkinson’s Disease Rating Scale, ON under dopaminergic medication, Off after dopaminergic withdrawal, LEDD levodopa equivalent daily dosage, PD subtype parkinsonian subtype, AR akinetic–rigidic, TD tremor-dominant, MT mixed type, LI laterality index, MMSE mini mental state examination, BDI-II Beck’s depression inventory, version II, BIS-11 Barrat impulsiveness scale, version 11, HPS hypomanic personality scale, DRD 3 dopamine receptor, DRD 2 D2 dopamine receptor
Back to article page